# Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization

> **NCT06232889** · NA · RECRUITING · sponsor: **UMC Utrecht** · enrollment: 15 (estimated)

## Conditions studied

- Fluorodeoxyglucose F18
- Phosphoric Monoester Hydrolases
- Phosphoric Diester Hydrolases

## Interventions

- **DIAGNOSTIC_TEST:** Deuterium Glucose Metabolic Imaging with MRI spectroscopy

## Key facts

- **NCT ID:** NCT06232889
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06232889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06232889, "Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06232889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*